The weekly litigation news digest is live. Subscribe now

IP Verse

Pharmaceutical Compositions Comprising Flurbiprofen - EP2892528

The patent EP2892528 was granted to Reckitt Benckiser on May 15, 2019. The application was filed on Sep 9, 2013 under application number EP13836176A. The patent is currently recorded with a legal status of "Revoked".

EP2892528

RECKITT BENCKISER
Application Number
EP13836176A
Filing Date
Sep 9, 2013
Status
Revoked
Apr 19, 2024
Publication Date
May 15, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBBFeb 17, 2020TER MEER STEINMEISTER & PARTNERADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS2003139437
INTERNATIONAL-SEARCH-REPORTUS2006241175
INTERNATIONAL-SEARCH-REPORTUS2010022608
INTERNATIONAL-SEARCH-REPORTUS5322689
INTERNATIONAL-SEARCH-REPORTWO2012044736
OPPOSITIONUS2010022608
OPPOSITIONWO2004096174
OPPOSITIONWO2006092569
OPPOSITIONWO2012080718
SEARCHGB2423710
SEARCHUS5025019

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents